PB

Probir Boiragi

Active Director Designated Partner DIN 09039196
DIN 09039196 First appointment Jan 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Probir Boiragi

Data last updated:

Probir Boiragi is a Designated Partner at Healpoint Diagnostics & Multi Speciality Clinic Llp (since 2021). The company operates in Healthcare.

DIN 09039196
Primary Designation Designated Partner
Industry Healthcare
First Appointment 22 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Jan 20212021Active

Board colleagues of Probir Boiragi

NameDINCompanyDesignation
Priyanshu Boiragi09039195Healpoint Diagnostics & Multi Speciality Clinic LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Healpoint Diagnostics & Multi Speciality Clinic Llp
Premium access

Shareholding and investment profile for Probir Boiragi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Probir Boiragi

Probir Boiragi currently holds 1 directorship: Healpoint Diagnostics & Multi Speciality Clinic Llp (Designated Partner, since 22 Jan 2021).

Probir Boiragi was first appointed on 22 Jan 2021 as Designated Partner at Healpoint Diagnostics & Multi Speciality Clinic Llp.

The current boards of Probir Boiragi's companies include Priyanshu Boiragi (Healpoint Diagnostics & Multi Speciality Clinic Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available